Dagondon, Edwina .
HRN: 08-16-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2023
CEFTRIAXONE 1G (VIAL)
06/23/2023
06/29/2023
IV
2 Grams
OD
Uti
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes